semaglutide intolerance Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Comparative safety and side effects

Follow these tips to keep yourself hydrated and to prevent electrolyte imbalance: Drink plenty of water regularly throughout the day, even if you are not thirsty

In England, this recommendation is mandatory for NHS funding, though access may be limited by supply and service capacity

High BMI Your doctor may prescribe GLP-1 drugs if you have a high body mass index (BMI) of 30 or more

doi: 10.2147/TCRM.S531645

Research from the STEP trials, which studied semaglutide 2.4mg weekly, found that approximately 75% of the weight lost was fat mass rather than lean mass

Reflecting this, a recent assessment of the states that use the federally facilitated marketplace (Healthcare.gov) found that fewer than 1% of plans covered Wegovy for weight loss